13F-HR/A filed by STEMPOINT CAPITAL LP
STEMPOINT CAPITAL LP filed this 13F-HR/A for the quarter ended 2026-03-31, filed 2026-05-18, with 82 holding rows worth $522,348,745.
- Accession
- 0001420506-26-001177
- Filer
- CIK 1952142
- Filed
- 2026-05-18
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, amendment of type new holdings, 84 entries on the cover page, a total value of $522,348,745 stated on the cover page (in dollars after the unit check, H1), rows summing to $522,348,745 with VALUE read as dollars as filed, 13F file number 028-23724. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 1,035,496 | $50,904,983 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 313,791 | $34,940,628 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,215,743 | $28,399,756 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 281,632 | $27,388,712 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 746,494 | $18,542,911 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 56,267 | $18,128,665 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 499,469 | $14,909,150 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 533,378 | $14,449,210 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 363,438 | $14,246,770 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 205,622 | $13,916,497 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 1,594,491 | $13,489,394 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 525,639 | $13,460,995 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 385,800 | $10,686,660 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 810,764 | $10,450,748 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 413,792 | $9,748,940 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 200,267 | $9,652,869 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 669,685 | $9,308,622 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 506,075 | $9,175,140 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 290,864 | $9,162,216 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 129,577 | $8,540,420 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 167,606 | $8,454,047 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 426,561 | $8,189,971 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 140,755 | $8,184,903 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 254,267 | $8,065,349 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 72,577 | $7,649,616 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 193,177 | $7,398,679 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 85,502 | $7,175,328 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 60,062 | $6,855,477 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 325,483 | $6,151,629 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 338,654 | $5,923,058 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 180,658 | $5,782,863 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 242,566 | $5,399,519 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 185,435 | $5,145,821 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 229,566 | $5,057,339 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 315,226 | $4,886,003 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 753,520 | $4,483,444 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 193,777 | $4,385,357 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 200,919 | $4,203,225 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 132,873 | $4,188,157 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 597,409 | $4,157,967 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 239,861 | $3,880,951 | dollars as filed | |
| Johnson & Johnson | 478160104 | COM | 15,415 | $3,768,043 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 850,742 | $3,513,564 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 59,061 | $3,432,035 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 939,369 | $3,240,823 | dollars as filed | |
| HELIX ACQUISITION CORP III | G4444S107 | USD CL A ORD SHS | 305,028 | $3,099,084 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 188,700 | $3,017,313 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 80,492 | $2,846,197 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 86,637 | $2,447,495 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 1,874,546 | $2,436,910 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 154,034 | $2,164,178 | dollars as filed | |
| TWIST BIOSCIENCE CORP | 90184D100 | COM | 43,110 | $2,048,587 | dollars as filed | |
| MAPLIGHT THERAPEUTICS INC | 56565P103 | COMMON STOCK | 100,000 | $2,033,000 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 134,742 | $2,011,698 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 26,385 | $1,981,250 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 63,543 | $1,915,821 | dollars as filed | |
| FORTE BIOSCIENCES INC | 34962G208 | COMMON STOCK | 58,020 | $1,502,718 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 36,540 | $1,464,889 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 375,000 | $1,436,250 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 195,403 | $1,406,902 | dollars as filed | |
| LIPOCINE INC NEW | 53630X203 | COM NEW | 160,420 | $1,281,756 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 78,066 | $1,276,379 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 50,000 | $1,233,000 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 453,236 | $1,192,011 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 14,588 | $1,168,207 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 37,592 | $1,142,797 | dollars as filed | |
| BIODESIX INC COM | 09075X207 | Stock | 70,004 | $1,015,058 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 100,000 | $588,000 | dollars as filed | call |
| SUTRO BIOPHARMA INC | 869367201 | COMMON STOCK | 23,295 | $580,278 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 100,000 | $525,000 | dollars as filed | put |
| SPRUCE BIOSCIENCES INC | 85209E208 | COM NEW | 6,360 | $415,626 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 100,000 | $290,000 | dollars as filed | call |
| IMMUNOVANT INC | 45258J102 | COM | 100,000 | $255,000 | dollars as filed | call |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 150,000 | $164,250 | dollars as filed | call |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 150,000 | $90,000 | dollars as filed | call |
| SPY | 78462F103 | SHS | 50,000 | $85,500 | dollars as filed | call |
| INVESCO QQQ TR | 46090E103 | COM | 40,000 | $74,200 | dollars as filed | call |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 616,749 | $58,187 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 250,000 | $12,500 | dollars as filed | call |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 100,000 | $7,500 | dollars as filed | call |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 25,000 | $3,750 | dollars as filed | call |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 10,000 | $1,000 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-001107 | superseded | 2026-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001420506-26-001177 | this filing | 2026-05-18 | acceptance time not in the bulk data set |